Edition:
India

Diffusion Pharmaceuticals Inc (DFFN.OQ)

DFFN.OQ on NASDAQ Stock Exchange Capital Market

2.03USD
21 Aug 2019
Change (% chg)

-- (--)
Prev Close
$2.03
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
65,269
52-wk High
$10.98
52-wk Low
$1.85

Latest Key Developments (Source: Significant Developments)

Diffusion Pharmaceuticals Reports Favorable Safety Data For Dose-Escalation Run-In
Tuesday, 23 Jul 2019 

July 23 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS REPORTS FAVORABLE SAFETY DATA FOR DOSE-ESCALATION RUN-IN OF PHASE 3 INTACT STUDY IN GLIOBLASTOMA MULTIFORME PATIENTS.DIFFUSION PHARMACEUTICALS INC - ADVERSE EVENTS SEEN WERE CONSISTENT WITH NATURAL HISTORY OF NEWLY DIAGNOSED INOPERABLE GBM PATIENTS..DIFFUSION PHARMACEUTICALS - DSMB RECOMMENDED CONTINUATION OF PHASE 3 CLINICAL TRIAL WITH TRANS SODIUM CROCETINATE (TSC) IN INOPERABLE GBM PATIENTS.DIFFUSION PHARMA - DSMB RECOMMENDED THAT HIGHEST DOSE ADMINISTERED, 1.5 MG/KG OF TSC, BE USED DURING ADJUVANT TREATMENT PERIOD OF PHASE 3 INTACT TRIAL.  Full Article

Diffusion Pharmaceuticals Announces $6.45 Million Registered Direct Offering & Private Placement
Friday, 24 May 2019 

May 24 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS INC. ANNOUNCES $6.45 MILLION REGISTERED DIRECT OFFERING & PRIVATE PLACEMENT.DIFFUSION PHARMACEUTICALS INC. ANNOUNCES $6.45 MILLION REGISTERED DIRECT OFFERING & PRIVATE PLACEMENT.DIFFUSION PHARMACEUTICALS INC - REGISTERED DIRECT OFFERING AT A PRICE OF $4.77 PER SHARE.DIFFUSION PHARMACEUTICALS INC - ALSO AGREED TO ISSUE 1.3 MILLION UNREGISTERED WARRANTS TO INSTITUTIONAL INVESTORS IN A CONCURRENT PRIVATE PLACEMENT.  Full Article

Diffusion Pharmaceuticals Files For Mixed Shelf Offering Of Up To $50 Million - SEC Filing
Friday, 17 May 2019 

May 16 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS INC - FILES FOR MIXED SHELF OFFERING OF UP TO $50 MILLION - SEC FILING.  Full Article

Diffusion Pharmaceuticals Reports 2018 Financial Results
Wednesday, 20 Mar 2019 

March 20 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS REPORTS 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.DIFFUSION PHARMACEUTICALS INC - DIFFUSION HAD CASH AND CASH EQUIVALENTS OF $8.0 MILLION AS OF DECEMBER 31, 2018.DIFFUSION PHARMACEUTICALS INC - BELIEVES ITS CASH AND CASH EQUIVALENTS ARE SUFFICIENT TO FUND OPERATIONS INTO JULY 2019.  Full Article

Diffusion Pharmaceuticals Announces 1-For-15 Reverse Stock Split
Friday, 14 Dec 2018 

Dec 13 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS ANNOUNCES 1-FOR-15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN.DIFFUSION PHARMACEUTICALS - REVERSE STOCK SPLIT OF SHARES OF COMMON STOCK AT RATIO OF 1-FOR-15, EFFECTIVE TO OPENING OF MARKET ON DEC 14, 2018.  Full Article

FDA Approves Start Phase 2 Clinical Trial For Treatment Of Acute Stroke By Diffusion Pharmaceuticals
Wednesday, 12 Sep 2018 

Sept 12 (Reuters) - Diffusion Pharmaceuticals Inc ::FDA APPROVES START OF INNOVATIVE ON-AMBULANCE PHASE 2 CLINICAL TRIAL FOR TREATMENT OF ACUTE STROKE BY DIFFUSION PHARMACEUTICALS.DIFFUSION PHARMACEUTICALS - RECEIVED FDA APPROVAL TO ENROLL PATIENTS IN PHASE 2 CLINICAL TRIAL TESTING FOR TREATMENT OF ACUTE STROKE.  Full Article

Diffusion Pharmaceuticals Announces $12 Mln Underwritten Public Offering
Thursday, 18 Jan 2018 

Jan 18 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS ANNOUNCES $12 MILLION UNDERWRITTEN PUBLIC OFFERING.DIFFUSION PHARMACEUTICALS- ‍PRICED PUBLIC OFFERING OF 15 MILLION SHARES, WITH WARRANTS TO PURCHASE UP TO 15 MILLION SHARES, AT $0.80/SHARE, ASSOCIATED WARRANT​.  Full Article

Diffusion Pharmaceuticals Begins Phase 3 Clinical Trial With TSC In Glioblastoma Multiforme
Wednesday, 27 Dec 2017 

Dec 27 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS BEGINS PHASE 3 CLINICAL TRIAL WITH TSC IN GLIOBLASTOMA MULTIFORME.DIFFUSION PHARMA - PROJECTS ENROLLMENT WILL BE COMPLETED BY EARLY 2019, WITH INTERIM SAFETY, EFFICACY DATA POSSIBLE IN 2020, TRIAL COMPLETION IN 2021.  Full Article

Diffusion Pharma Files For Stock Offering For Up To About $15 Mln
Thursday, 21 Dec 2017 

Dec 20 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS FILES FOR STOCK OFFERING FOR UP TO ABOUT $15 MILLION - SEC FILING.  Full Article

Diffusion Pharmaceuticals reports qtrly net income per diluted share $0.20‍​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Diffusion Pharmaceuticals Inc :Diffusion Pharmaceuticals Inc qtrly net income per diluted share $0.20‍​.Diffusion Pharmaceuticals Inc - ‍remain on track to begin enrolling patients by end of 2017 for tsc glioblastoma phase 3 pivotal study​.Diffusion Pharmaceuticals Inc - ‍awaiting confirmation from Nasdaq that co demonstrated compliance with all applicable requirements for continued listing​.  Full Article